Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML

NCT04365179 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced MDS
AML

Interventions

DRUG: Nerofe

Sponsor

Immune System Key Ltd

Collaborators

[object Object]